Solvay SA
Solvay SA (SVYSF) Financial Performance & Income Statement Overview
Analyze Solvay SA (SVYSF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Solvay SA (SVYSF) Income Statement & Financial Overview
Review Solvay SA SVYSF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.24B | $1.25B | $1.25B | $1.33B |
| Cost of Revenue | $991.00M | $981.00M | $971.00M | $1.02B |
| Gross Profit | $252.00M | $273.00M | $275.00M | $309.00M |
| Gross Profit Ratio | $0.20 | $0.22 | $0.22 | $0.23 |
| R&D Expenses | -$4.00M | $10.00M | $9.00M | $8.00M |
| SG&A Expenses | $105.00M | $108.00M | $106.00M | $101.00M |
| Operating Expenses | $105.00M | $148.00M | $115.00M | $109.00M |
| Total Costs & Expenses | $1.10B | $1.13B | $1.09B | $1.13B |
| Interest Income | $3.00M | $5.00M | $4.00M | $5.00M |
| Interest Expense | $24.00M | $25.00M | $27.00M | $29.00M |
| Depreciation & Amortization | $80.00M | $91.00M | $88.00M | $96.00M |
| EBITDA | $230.00M | $153.00M | $152.00M | $274.00M |
| EBITDA Ratio | $0.19 | $0.12 | $0.12 | $0.21 |
| Operating Income | $147.00M | $125.00M | $131.00M | $200.00M |
| Operating Income Ratio | $0.12 | $0.10 | $0.11 | $0.15 |
| Other Income/Expenses (Net) | -$32.00M | -$84.00M | -$102.00M | -$85.00M |
| Income Before Tax | $115.00M | $41.00M | $29.00M | $105.00M |
| Income Before Tax Ratio | $0.09 | $0.03 | $0.02 | $0.08 |
| Income Tax Expense | $32.00M | $8.00M | $11.00M | $42.00M |
| Net Income | $81.00M | $30.00M | $19.00M | $67.00M |
| Net Income Ratio | $0.07 | $0.02 | $0.02 | $0.05 |
| EPS | $0.78 | $0.29 | $0.18 | $0.64 |
| Diluted EPS | $0.77 | $0.28 | $0.18 | $0.63 |
| Weighted Avg Shares Outstanding | $104.48M | $104.47M | $104.09M | $105.46M |
| Weighted Avg Shares Outstanding (Diluted) | $105.61M | $105.46M | $105.20M | $106.61M |
Over the last four quarters, Solvay SA's revenue moved from $1.33B in Q2 2024 to $1.24B in Q1 2025. Operating income in Q1 2025 was $147.00M, with a strong operating margin of 12%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Solvay SA remained robust at $230.00M, reflecting operational efficiency. Net income rose to $81.00M, with an EPS of $0.78. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan